However, Hao et al. demonstrated that praziquantel has an antiproliferative effect during the treatment of psoriasis in mice by inhibiting STAT3 phosphorylation, thereby suppressing Th17 immunity [45]. The gene discussed is STAT3; the disease is psoriasis.